Sign In
Buy COCP
$1.06
+0.0100 (+0.95%)
At Close: Jun 03, 2026
Gilead Sciences: Rapidly Building Up One Of The World's Best-Recognized Brands
08:55am, Thursday, 07'th May 2020
Gilead Sciences has an impressive portfolio of assets, but its brand is quickly becoming better known as a result of its COVID-19 drug. Outside of this, the com
Gilead Sciences: Still A Core Holding
08:12pm, Saturday, 02'nd May 2020
I have held a significant position in Gilead which has served me well in recent weeks. Investors are fearful that Gilead might contribute to solving COVID-19 bu
This Year's Tax-Loss-Selling Recovery Portfolio Is a Real Loser So Far
03:00pm, Friday, 01'st May 2020
This experiment in trying to identify stocks that could come back after dismal year-ago performance isn't going well five months since its inception.
CMG, CLDX among premarket gainers
01:19pm, Wednesday, 22'nd Apr 2020
SAExploration Holdings (NASDAQ:SAEX) +177% on $27M new project in Greece.B.O.S. Better Online Solutions (NASDAQ:BOSC) +56% on $1M order.The Peck Company Holdings (NASDAQ:PECK) +51% on partnership w
Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced today tha
Cocrystal Pharma Announces Appointment of Nobel Laureate and Scientific Advisor, Roger D. Kornberg, Ph.D., to Board of Directors
12:05pm, Monday, 20'th Apr 2020
- Work completed over decades of renowned biochemist’s career serves as basis for Company’s structure-based technology which has demonstrated broad utility in development of.
MT, SSL among premarket losers
01:16pm, Wednesday, 15'th Apr 2020
Obalon Therapeutics (NASDAQ:OBLN) -25%.NeuroMetrix (NASDAQ:NURO) -16%.Cocrystal Pharma (NASDAQ:COCP) -14%.Covanta Holding (NYSE:CVA) -12% on dividend cut and guidance pull.Independence Contract Dri
Cocrystal Pharma to Present at the April 2020 Virtual Investor Summit
12:05pm, Wednesday, 15'th Apr 2020
A live audio webcast of the presentation will be available on the IR Calendar page of the Investors section of the Company’s website (cocrystalpharma.com). Cocrystal employs unique structure-based
Needed: A Master Plan for Covid-19 Patents
01:22pm, Friday, 10'th Apr 2020
Disputes over access to coronavirus treatments are already simmering. The Medicines Patent Pool could help everyone get access to the medicines they need.
JTC Team and LaVoieHealthScience to Host Virtual Investor Summit on April 22 and 23, 2020
02:26pm, Thursday, 09'th Apr 2020
Press Release JTC Team ("JTC") and LaVoieHealthScience ("LHS"), today announced their partnership to host the April 2020 Virtual Investor Summit on April 22nd and 23rd from 10:00 AM - 12:00 PM ET and
JTC Team and LaVoieHealthScience to Host Virtual Investor Summit on April 22 and 23, 2020
02:10pm, Thursday, 09'th Apr 2020
The Virtual Investor Summit features public and private companies from industries such as life sciences/biotech, infrastructure and transportation.
Best free photography courses, apps and YouTube channels for lockdown learning
04:02pm, Friday, 03'rd Apr 2020
How to emerge from self-isolation with new snapping skills
Bay Area scientists forge alliance to stop coronavirus — it may prove key to cure
11:00am, Friday, 03'rd Apr 2020
Bay Area scientists, doctors and medical researchers are at the forefront, trying to unlock the secrets of the coronavirus, studying therapies and hastening toward a treatment or a cure. We talk with
Cocrystal Pharma Reports 2019 Financial Results and Outlines Expected Value-Driving Milestones for 2020
10:05am, Monday, 30'th Mar 2020
Advancing preclinical COVID-19 Coronavirus program leveraging patent rights recently acquired from Kansas State University Research Foundation (“KSURF”) Continuing collaboration.
Tax reforms for digital and multinational companies of 137 countries - CityAM
09:54am, Monday, 30'th Mar 2020
At the Organisation for Economic Co-operation and Development’s (OECD) headquarters in Paris, negotiations are underway between 137 countries, on major
